Register Login
Register to leave comments
  • News bot July 31, 2026, 12:50 p.m.

    📋 VISTAGEN THERAPEUTICS, INC. (VTGN) - Clinical Trial Update

    Filing Date: 2026-07-31

    Accepted: 2026-07-31 08:48:17

    Event Type: Clinical Trial Update

    Event Details:

    VISTAGEN THERAPEUTICS, INC. (VTGN) Announces Clinical Trial Update VISTAGEN THERAPEUTICS, INC. (VTGN) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: experience
    • Diseases/Conditions: neuroscience drug development
    • Collaboration: Board of DirectorsDr

    🔬 Clinical Development Pipeline (VISTAGEN THERAPEUTICS, INC.):

    Product Type Development Stage Therapeutic Area Source
    Placebo Nasal Spray Other Phase PHASE3 Social Anxiety Disorder (SAD) ClinicalTrials.gov
    Fasedienol Nasal Spray Other Phase PHASE3 Social Anxiety Disorder (SAD) ClinicalTrials.gov
    PH94B Nasal Spray Other Phase PHASE3 Social Anxiety Disorder ClinicalTrials.gov
    Placebo Other Phase PHASE1 Neuropathic Pain ClinicalTrials.gov
    AV-101 Other Phase PHASE1 Neuropathic Pain ClinicalTrials.gov
    AV-101 1440 mg Other Phase PHASE1 Healthy ClinicalTrials.gov
    AV-101 720 mg Other Phase PHASE1 Healthy ClinicalTrials.gov
    Probenecid Other Phase PHASE1 Drug Drug Interaction ClinicalTrials.gov
    PH94B Other Phase PHASE2 Adjustment Disorder With Anxious Mood ClinicalTrials.gov
    Placebo Nasal Spray - Placebo Nasal Spray Other Phase PHASE2 Social Anxiety Disorder ClinicalTrials.gov
    Fasedienol Nasal Spray - Fasedienol Nasal Spray Other Phase PHASE2 Social Anxiety Disorder ClinicalTrials.gov
    Fasedienol Nasal Spray - Placebo Nasal Spray Other Phase PHASE2 Social Anxiety Disorder ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: VISTAGEN THERAPEUTICS, INC.
    • Ticker Symbol: VTGN

Search

News categories